Compounds > 1,4,7-tris(carboxymethyl)-1,4,7,10-tetraazacyclododecane
Page last updated: 2024-09-02

1,4,7-tris(carboxymethyl)-1,4,7,10-tetraazacyclododecane and Bone Cancer

1,4,7-tris(carboxymethyl)-1,4,7,10-tetraazacyclododecane has been researched along with Bone Cancer in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hajibeigi, A; Kovacs, Z; Lin, M; Liu, W; Oz, OK; Rostollan, CL; Sun, X1

Other Studies

1 other study(ies) available for 1,4,7-tris(carboxymethyl)-1,4,7,10-tetraazacyclododecane and Bone Cancer

ArticleYear
An osteoclast-targeting agent for imaging and therapy of bone metastasis.
    Bioorganic & medicinal chemistry letters, 2008, Sep-01, Volume: 18, Issue:17

    Topics: Animals; Bone Neoplasms; Cells, Cultured; Diagnostic Imaging; Diphosphonates; Heterocyclic Compounds, 1-Ring; Indium Radioisotopes; Male; Mice; Mice, Inbred BALB C; Osteoclasts; Radionuclide Imaging

2008